PTU-152 Significant Improvements in Abdominal Pain and Bowel Symptoms in a Phase 3 Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): A European Perspective

Gut - United Kingdom
doi 10.1136/gutjnl-2012-302514c.152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

PWE-026 Effects of 26 Weeks of Linaclotide Treatment on Adequate Relief and IBS Severity in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): Abstract PWE-026 Table

Gut
Gastroenterology
2013English

Clinical Response to Linaclotide at Week 4 Predicts Sustained Response in Irritable Bowel Syndrome With Constipation and Improvements in Digestive and Extra-Digestive Symptoms

Therapeutic Advances in Gastroenterology
Gastroenterology
2019English

Linaclotide: A New Option for the Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation in Adults

Clinical Medicine Insights: Gastroenterology
Gastroenterology
2013English

Review: Soluble Fibre Improves Overall Symptoms and Constipation but Not Abdominal Pain in Irritable Bowel Syndrome

Evidence-Based Medicine
Medicine
2004English

PWE-167 Effect of Linaclotide on Ibs-Qol Sexual Subscale Scores in Patients With Irritable Bowel Syndrome With Constipation: Results From 2 Phase 3 Trials: Abstract PWE-167 Table 1

Gut
Gastroenterology
2014English

Abdominal Bloating Is the Most Bothersome Symptom in Irritable Bowel Syndrome With Constipation (IBS-C): A Large Population-Based Internet Survey in Japan

BioPsychoSocial Medicine
PsychiatrySocial PsychologyMental HealthPsychologyBiological Psychiatry
2016English

Lovastatin Lactone May Improve Irritable Bowel Syndrome With Constipation (IBS-C) by Inhibiting Enzymes in the Archaeal Methanogenesis Pathway

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Faecal Biomarker Patterns in Patients With Symptoms of Irritable Bowel Syndrome

Frontline Gastroenterology
HepatologyGastroenterology
2016English

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation

American Journal of Gastroenterology
HepatologyGastroenterology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy